Stocks making the biggest moves midday: ResMed, Affirm, Nvidia, Anheuser-Busch and more

by | Jun 24, 2024 | Financial

Check out the companies making the biggest moves midday: Inspire Medical Systems , ResMed — Inspire Medical Systems and ResMed, which manufacture devices to treat obstructive sleep apnea, dropped 14% and 11%, respectively, following Friday’s news that Eli Lilly ‘s weight loss drug tirzepatide reduced the severity of the condition. Eli Lilly also said it applied for approval from the Food and Drug Administration for the drug’s treatment of sleep apnea. Eli Lilly’s stock advanced 2%. RXO — Shares jumped 23% after the freight company said it struck a deal to buy Coyote Logistics from UPS for more than $1 billion. UPS was up 1.5%. Alnylam Pharmaceuticals — The clinical-stage therapeutics company soared 37% after a phase three study found that its drug vutrisiran showed a statistically significant reduction in the number of deaths and cardiovascular events in patients with ATTR amyloidosis with cardiomyopathy. Nvidia — Shares shed nearly 5%. Nvidia’s latest decline adds to last week’s drop of 4% when it snapped its eight-week winning streak. The artificial intelligence darling had briefly dethroned Microsoft as the most valuable company in the U.S. last week. Affirm — The buy now, pay later stock popped 10% after Goldman Sachs assumed coverage of the name at a buy rating. Analyst Will Nance cited the stock’s strong fundamentals, including its differentiated credit underwriting approach, as catalysts …

Article Attribution | Read More at Article Source

[mwai_chat context=”Let’s have a discussion about this article:nnCheck out the companies making the biggest moves midday: Inspire Medical Systems , ResMed — Inspire Medical Systems and ResMed, which manufacture devices to treat obstructive sleep apnea, dropped 14% and 11%, respectively, following Friday’s news that Eli Lilly ‘s weight loss drug tirzepatide reduced the severity of the condition. Eli Lilly also said it applied for approval from the Food and Drug Administration for the drug’s treatment of sleep apnea. Eli Lilly’s stock advanced 2%. RXO — Shares jumped 23% after the freight company said it struck a deal to buy Coyote Logistics from UPS for more than $1 billion. UPS was up 1.5%. Alnylam Pharmaceuticals — The clinical-stage therapeutics company soared 37% after a phase three study found that its drug vutrisiran showed a statistically significant reduction in the number of deaths and cardiovascular events in patients with ATTR amyloidosis with cardiomyopathy. Nvidia — Shares shed nearly 5%. Nvidia’s latest decline adds to last week’s drop of 4% when it snapped its eight-week winning streak. The artificial intelligence darling had briefly dethroned Microsoft as the most valuable company in the U.S. last week. Affirm — The buy now, pay later stock popped 10% after Goldman Sachs assumed coverage of the name at a buy rating. Analyst Will Nance cited the stock’s strong fundamentals, including its differentiated credit underwriting approach, as catalysts …nnDiscussion:nn” ai_name=”RocketNews AI: ” start_sentence=”Can I tell you more about this article?” text_input_placeholder=”Type ‘Yes'”]
Share This